What is the translation of " OVERALL DATA " in Danish?

['əʊvərɔːl 'deitə]
['əʊvərɔːl 'deitə]

Examples of using Overall data in English and their translations into Danish

{-}
  • Medicine category close
  • Official category close
  • Colloquial category close
  • Financial category close
  • Ecclesiastic category close
  • Official/political category close
  • Computer category close
Overall data show that the Belgian performance is average.
Sammenfattende data viser, at de belgiske resultater er gennemsnitlige.
A number of layers andtheir sequence depend on overall data about each layer in a borehole.
En række af lag ogderes rækkefølge afhænger samlede data om hvert lag i et borehul.
The overall data stored on it will erase and create new memory location to store data freshly.
De overordnede data gemt på det vil slette og oprette nye hukommelse placering til at gemme data frisk.
Make it an easy transition with the help of Coolmuster Mobile Transfer,which empowers you with the ability to transfer overall data.
Gør det en nem overgang ved hjælp af Coolmuster Mobile Transfer,som giver dig mulighed for at overføre generelle data mellem to.
If we take a broader range of safety indicators, overall data show that railway safety standards in Europe are generally very high.
Hvis vi ser på et bredere udvalg af sikkerhedsindikatorer, viser de overordnede data, at standarderne for jernbanesikkerhed generelt er meget høje i Europa.
Make it an easy transition with the help of Coolmuster Mobile Transfer,which empowers you with the ability to transfer overall data….
Gà ̧r det en nem overgang ved hjælp af Coolmuster Mobile Transfer, som giver dig mulighed for atoverfà ̧re generelle data mellem to….
The Applicant considered that the overall data demonstrate that spacer use results in the same high extent of in vitro equivalence as inhaler testing without this device.
Ansøgeren mente, at de generelle data viser, at anvendelse af spacer resulterer i den samme høje grad af in vitro- ækvivalens som inhalatortestning uden denne anordning.
Make it an easy transition with the help of Coolmuster Mobile Transfer,which empowers you with the ability to transfer overall data between two mobile phones.
Gà ̧r det en nem overgang ved hjælp af Coolmuster Mobile Transfer, som giver dig mulighed for atoverfà ̧re generelle data mellem to mobiltelefoner.
Children and adolescents Overall data from clinical trials indicate an increased risk of suicidal and hostility related behaviours in the paediatric population 7-17 years old.
Børn og unge De samlede data fra kliniske forsøg antyder, at der er en øget risiko for selvmordsrelateret og fjendtlig adfærd hos den pædiatriske population 7- 17 år gamle.
It is equipped with the advanced error correction code engine for enhancing the reliability of the card as well as the overall data integrity during read and write.
Den er udstyret med den avancerede fejlkorrektionskode motor til øge pålideligheden af kortet samt den overordnede data integritet under læse- og skrive.
During its January 2005 meeting, the CHMP, in the light of the overall data submitted and the scientific discussion within the Committee, was of the opinion that a marketing authorisation should be granted.
På sit møde i januar 2005 var CHMP på grundlag af de samlede forelagte oplysninger og den faglige drøftelse i udvalget af den opfattelse, at der skulle udstedes en markedsføringstilladelse.
Created with the latest technology of the time, this SanDisk SDSDXPA -064 G-AFFP captures Full HD video.It is equipped with the advanced error correction code engine for enhancing the reliability of the card as well as the overall data integrity during read and write.
Lavet med den nyeste teknologi af tiden,denne SanDisk SDSDXPA-064G-AFFP indfanger Full HD-video. Den er udstyret med den avancerede fejlkorrektionskode motor til øge pålideligheden af kortet samt den overordnede data integritet under læse- og skrive.
During its June 2005 meeting, the CHMP, in the light of the overall data submitted and the scientific discussion within the Committee, was of the opinion that the benefit/ risk ratio is favourable for Lansopon.
På sit møde i juni 2005 var CHMP på grundlag af de samlede forelagte oplysninger og den faglige drøftelse i udvalget af den opfattelse, at benefit/ risk- forholdet var gunstigt for Lansopon.
Such checks shall focus on overall data relating to that period for the manufacturers and buyers concerned, and on at least 10% of all the transactions and utilizations which have taken place.
Den verdroerer alle oplysninger om denne periode for hver af de beroerte fabrikanter og opkoebere, og skal mindst omfatte 10% af alle de transaktioner og anvendelser, som har fundet sted i den eller de paagaeldende medlemsstater.
At that time, no one, not the government, the WFP or the NGOs, were able,due to the lack of precise overall data, to assess whether it was a slightly more difficult crisis than in previous years or a serious food crisis.
På daværende tidspunkt var ingen- hverken regeringen, WFP eller ngo'erne- i stand til at vurdere, omder var tale om en lidt vanskeligere krise end de tidligere år eller om en alvorlig fødevarekrise, eftersom der ikke var nogen samlede præcise oplysninger.
During its July 2008 meeting, the CVMP, in light of the overall data submitted and the scientific discussion within the Committee, adopted by consensus an opinion concluding that the assessment of the risk presented by toltrazuril and its major metabolite, toltrazuril sulfone, to terrestrial plants and to groundwater demonstrated that use of products containing toltrazuril is acceptable.
På baggrund af de samlede fremlagte oplysninger og den faglige drøftelse i udvalget vedtog CVMP på mødet i juli 2008 ved konsensus en udtalelse, hvori det konkluderes, at vurderingen af den risiko, som toltrazuril og dets vigtigste metabolit, toltrazurilsulfon, frembyder for terrestriske planter og grundvandet, viste, at brugen af produkter indeholdende toltrazuril er acceptabel.
During its April 2005 meeting, the CHMP, in the light of the overall data submitted and the scientific discussion within the Committee, was of the opinion that the benefit/ risk ratio is favourable for Crestor 5 mg or Crestor 10 mg as start dose.
På sit møde i april 2005 var CHMP på grundlag af de samlede forelagte oplysninger og den faglige drøftelse i udvalget af den opfattelse, at benefit/ risk- forholdet var gunstigt for Crestor 5 mg eller Crestor 10 mg som startdosis.
During their September 2006 meeting, the CHMP, in the light of the overall data submitted and the scientific discussion within the Committee, was of the opinion that the benefit/ risk ratio is favourable for Glucomed and associated names for the relief of symptoms in mild to moderate osteoarthritis of the knee, that there was no objection for the granting of a Marketing Authorisation and that the Summary of Product Characteristics, labelling and package leaflet of the Reference Member State.
På sit møde i september 2006 var CHMP på grundlag af de samlede forelagte oplysninger og de faglige drøftelser i udvalget af den opfattelse, at risk/ benefit- forholdet var gunstigt for Glucomed og tilknyttede navne til symptomlindring ved mild til moderat slidgigt i knæet, og der ikke var.
Time budgets by socio-occupational group and sex;- normal pattern of the year(number of days worked;length of holidays; overall data on absenteeism if possible);- average length of working week and working day;- data on"constrained time"(working time+ journey time);- phases of life: a statutory retirement age; average actual age; trends; b ages of entry into the labour market.
Tidsbudgetter efter socioerhvervsmæssig gruppe og køn- årets normale mønster(antal arbejdsdage;feriernes længde; generelle data om fravær, hvis det er muligt)- gennemsnitlig længde af arbejdsugen og arbejdsdagen- data om"indskrænket tid"(arbejdstid+ rejsetid)- livsfaser: a lovmæssig pensionsalder; gennemsnitlig faktisk alder; tendenser og udviklinger b aldre for optagelse på arbejdsmarkedet.
During the June 2006 meeting, the CHMP, in the light of the overall data submitted and the scientific discussion within the Committee, was of the opinion that the benefit/ risk ratio is favourable for Cardoreg 4 mg prolonged release tablets and associated names, that the objections raised should not prevent the granting of a Marketing Authorisation and that the Summary of Product Characteristics, labelling and package leaflet of the Reference Member State should be amended.
I lyset af de samlede data, der var blevet fremlagt, og den faglige debat i udvalget var CHMP på sit møde i juni 2006 af den opfattelse, at benefit- risk forholdet er gunstigt for Cardoreg 4 mg depottabletter og tilknyttede navne, at de rejste indvendinger ikke bør forhindre udstedelse af en markedsføringstilladelse, og at referencemedlemsstatens produktresumé, etikettering og indlægsseddel bør ændres.
During their May 2006 meeting, the CHMP, in the light of the overall data submitted and the scientific discussion within the Committee, was of the opinion that the benefit/ risk ratio is favourable for Ceftriaxone Tyrol Pharma and associated names, that the objections raised by United Kingdom should.
I lyset af de samlede data, der var blevet fremlagt, og den faglige debat i udvalget var CHMP på sit møde i maj 2006 af den opfattelse, at benefit- risk forholdet er gunstigt for Ceftriaxon Tyrol Pharma og.
During their April 2007 meeting, the CHMP, in the light of the overall data submitted and the scientific discussion within the Committee, was of the opinion that the objections raised by Spain could be agreed and that the Summary of Product Characteristics, labelling and package leaflet of the Reference Member State should be amended.
På mødet i april 2007 var CHMP på grundlag af de samlede forelagte oplysninger og den faglige drøftelse i udvalget af den opfattelse, at de indsigelser, der var rejst af Spanien, kunne godkendes, og at referencemedlemsstatens produktresumé, etikettering og indlægsseddel skulle ændres.
During its 12-15 September 2005 meeting, the CHMP, in the light of the overall data submitted and the scientific discussion within the Committee was of the opinion that a marketing authorisation should be granted subject to certain conditions considered essential for the safe and effective use of the medicinal product.
På sit møde den 12.- 15. juni 2005 var CHMP på grundlag af de samlede forelagte oplysninger og den faglige drøftelse i udvalget af den opfattelse, at der skulle udstedes en markedsføringstilladelse, forudsat at en række vigtige betingelser til sikring af en sikker og effektiv anvendelse af lægemidlet var opfyldt.
During their July 2008 meeting, the CHMP, in the light of the overall data submitted and the scientific discussion within the Committee, was of the opinion that the benefit/ risk ratio is favourable for Lisonorm, that the objections raised by Czech Republic and Latvia should not prevent the granting of a Marketing Authorisation.
På sit møde i juli 2008 var CHMP på grundlag af de samlede forelagte oplysninger og de faglige drøftelser i udvalget af den opfattelse, at risk/ benefit- forholdet var gunstigt for Lisonorm, og at Den Tjekkiske Republik og Letlands betænkeligheder ikke skulle forhindre udstedelse af en markedsføringstilladelse.
During their January 2007 meeting, the CHMP, in the light of the overall data submitted and the scientific discussion within the Committee, was of the opinion that the objections that triggered the Article 29 Referral, should not prevent the granting of a Marketing Authorisation for Alendronate HEXAL and associated names.
På sit møde i januar 2007 var CHMP på grundlag af de samlede forelagte oplysninger og den faglige drøftelse i udvalget af den opfattelse, at de indsigelser, der havde givet anledning til artikel 29- indbringelsen, ikke bør være til hinder for udstedelse af en markedsføringstilladelse for Alendronat HEXAL og tilknyttede navne.
During their April 2008 meeting, the CHMP, in the light of the overall data submitted and the scientific discussion within the Committee, was of the opinion that the objections that triggered the Article 29 Referral should not prevent the granting of a Marketing Authorisation for Oracea and that the Summary of Product Characteristics, labelling and package leaflet of the Reference Member State should be amended.
På grundlag af de samlede forelagte oplysninger og den faglige drøftelse i udvalget var CHMP på mødet i april 2008 af den opfattelse, at de indvendinger, der udløste indbringelsen i henhold til artikel 29, ikke burde forhindre udstedelse af markedsføringstilladelse for Oracea, og at referencemedlemsstatens produktresumé, etikettering og indlægsseddel bør ændres.
During their January 2007 meeting, the CHMP, in the light of the overall data submitted and the scientific discussion within the Committee, was of the opinion that the benefit/ risk ratio is favourable for Ciprofloxacin Hikma and associated names, that the objections raised should not prevent the granting of a Marketing Authorisation and that the Summary of Product Characteristics, labelling and package leaflet of the Reference Member State should be amended.
På sit møde i januar 2007 fandt CHMP på baggrund af alle de forelagte oplysninger og den faglige drøftelse i udvalget, at benefit- risk forholdet er gunstigt for Ciprofloxacin Hikma og tilknyttede navne, at de rejste indvendinger ikke bør forhindre udstedelse af en markedsføringstilladelse, og at referencemedlemsstatens produktresumé, etikettering og indlægsseddel bør ændres.
During their June 2008 meeting, the CHMP, in the light of the overall data submitted and the scientific discussion within the Committee, was of the opinion that the benefit/ risk ratio is favourable for Activelle and associated names, that the objections raised by France and Germany should not prevent the granting of a Marketing Authorisation and that the Summary of Product Characteristics, labelling and package leaflet of the Reference Member State should be amended.
Efter gennemgang af alle fremlagte oplysninger og den faglige drøftelse i Udvalget vurderede CHMP på sit møde i juni 2008, at benefit/ risk- forholdet for Activelle og tilknyttede navne er positivt, at Frankrigs og Tysklands indvendinger ikke skulle stå i vejen for udstedelse af en markedsføringstilladelse, og at produktresuméet, etiketteringen og indlægssedlen i referencemedlemsstaten skulle ændres.
During its January 2004 meeting, the CPMP, in the light of the overall data submitted and the scientific discussion within the Committee, was of the opinion that although, the development of the product and the presence of avoidable impurities have raised important quality concerns, there appears to be no safety concerns arising from the impurity profile in this product, based on the toxicology studies provided by the company.
I lyset af de samlede data, der var blevet fremlagt, og den faglige debat i udvalget var CPMP på sit møde i januar 2004 af den opfattelse, at der på grundlag af firmaets toksikologiske undersøgelser tilsyneladende ikke var alvorlige sikkerhedsproblemer som følge af dette produkts urenhedsprofil, selv om udviklingen af produktet og tilstedeværelsen af urenheder, som kunne undgås, havde vakt betydelige bekymringer med hensyn til kvaliteten.
During their November 2007 meeting, the CHMP, in the light of the overall data submitted and the scientific discussion within the Committee, was of the opinion that the benefit/ risk ratio is favourable for Menitorix, that the objections raised by Greece, Poland and Spain should not prevent the granting of a Marketing Authorisation and that the Summary of Product Characteristics, labelling and package leaflet of the Reference Member State should be amended.
I lyset af de samlede data, der var blevet fremlagt, og den faglige drøftelse i udvalget var CHMP på sit møde i november 2007 af den opfattelse, at benefit- risk forholdet er gunstigt for Menitorix, at de af Grækenland, Polen og Spanien rejste indvendinger ikke bør forhindre udstedelse af en markedsføringstilladelse, og at referencemedlemsstatens produktresumé, etikettering og indlægsseddel bør ændres.
Results: 420, Time: 0.0295

Word-for-word translation

Top dictionary queries

English - Danish